Literature DB >> 24402877

Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis.

Sevim Karakas Celik1, Zehra Safi Öz, Ahmet Dursun, Aysun Unal, Ufuk Emre, Salih Cicek, Fatih Mehmet Keni.   

Abstract

Proinflammatory cytokines with immunosuppressive properties play an important role in the pathogenesis of multiple sclerosis (MS). Interleukin 18 (IL-18) is one of the most important innate cytokines produced from macrophages in the early stages of the inflammatory immune response. The purpose of this study was to determine whether there was any relationship between IL18 gene polymorphisms and MS. IL18 genotyping were performed in 101 MS patients and 164 control subjects by using the PCR-restriction fragment length polymorphism (PCR-RFLP) method. The frequency of MS patients with the CC genotype of the IL18 gene at position -137 was significantly higher than with the GG genotype [p = 0.01, odds ratio (OR) 3.17]. In haplotype analysis of two SNPs in the IL18 gene, frequency of the CC haplotype was significantly higher in MS patients (p = 0.002, OR 3.0). However, the genotype distribution of the IL18 -607 C/A polymorphism in the MS patient group was not significantly different from that of the control group. These data suggest that IL18 gene polymorphisms at position -137 might be a genetic risk factor for MS in the Turkish population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402877     DOI: 10.1007/s11033-013-3013-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Interleukin-18 promoter polymorphism and asthma risk: a meta-analysis.

Authors:  Ying Ma; Bo Zhang; Ren-Kuan Tang; Yun Liu; Guo-Guang Peng
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

2.  Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation.

Authors:  V Giedraitis; B He; W X Huang; J Hillert
Journal:  J Neuroimmunol       Date:  2001-01-01       Impact factor: 3.478

3.  Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease.

Authors:  Laurence Tiret; Tiphaine Godefroy; Edith Lubos; Viviane Nicaud; David-Alexandre Tregouet; Sandrine Barbaux; Renate Schnabel; Christoph Bickel; Christine Espinola-Klein; Odette Poirier; Claire Perret; Thomas Münzel; Hans-Jurgen Rupprecht; Karl Lackner; François Cambien; Stefan Blankenberg
Journal:  Circulation       Date:  2005-07-25       Impact factor: 29.690

4.  Pro-inflammatory cytokine and chemokine mRNA blood level in multiple sclerosis is related to treatment response and interferon-beta dose.

Authors:  Angele Cucci; Pierangelo Barbero; Marinella Clerico; Bruno Ferrero; Elisabetta Versino; Giulia Contessa; Stefania Demercanti; Emanuela Viglietta; Alessandra Di Liberto; Alessandra Giai Vai; Luca Durelli
Journal:  J Neuroimmunol       Date:  2010-06-23       Impact factor: 3.478

5.  Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response.

Authors:  Jerome J Graber; David Ford; Min Zhan; Gordon Francis; Hillel Panitch; Suhayl Dhib-Jalbut
Journal:  J Neuroimmunol       Date:  2007-02-27       Impact factor: 3.478

6.  IL18 polymorphism is associated with an increased risk of Crohn's disease.

Authors:  Kazuo Tamura; Yoshihiro Fukuda; Hiroko Sashio; Naohisa Takeda; Hiroko Bamba; Tadashi Kosaka; Shin Fukui; Koji Sawada; Kazutami Tamura; Masamichi Satomi; Takahiro Yamada; Takehira Yamamura; Yoshihiro Yamamoto; Jun-ichi Furuyama; Haruki Okamura; Takashi Shimoyama
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

7.  Differential induction of interleukin-12, interleukin-18, and interleukin-1beta converting enzyme mRNA in experimental autoimmune encephalomyelitis of the Lewis rat.

Authors:  S Jander; G Stoll
Journal:  J Neuroimmunol       Date:  1998-11-02       Impact factor: 3.478

8.  The impact of IL18 gene polymorphisms on mRNA levels and interleukin-18 release by peripheral blood mononuclear cells.

Authors:  Violetta Dziedziejko; Mateusz Kurzawski; Edyta Paczkowska; Bogusław Machalinski; Andrzej Pawlik
Journal:  Postepy Hig Med Dosw (Online)       Date:  2012-06-20       Impact factor: 0.270

9.  IL-2, IFN-gamma, and IL-12 gene polymorphisms and susceptibility to multiple sclerosis.

Authors:  Mohammad Ali Shokrgozar; Sheila Sarial; Aliakbar Amirzargar; Fazel Shokri; Nima Rezaei; Zohreh Arjang; Jalaledin Radfar; Manijeh Yousefi-Behzadi; Mohammad Ali Sahraian; Jamshid Lotfi
Journal:  J Clin Immunol       Date:  2009-06-20       Impact factor: 8.317

10.  A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients.

Authors:  Y-J Lin; L Wan; J J-C Sheu; C-M Huang; C-W Lin; Y-C Lan; C-H Lai; C-H Hung; Y Tsai; C-H Tsai; T-H Lin; C-P Chen; F-J Tsai
Journal:  Lupus       Date:  2008-02       Impact factor: 2.911

View more
  7 in total

Review 1.  Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics.

Authors:  Yueran Cui; Haiyang Yu; Zhongqi Bu; Lulu Wen; Lili Yan; Juan Feng
Journal:  Front Mol Neurosci       Date:  2022-05-25       Impact factor: 6.261

Review 2.  Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.

Authors:  Yue Lang; Fengna Chu; Donghui Shen; Weiguanliu Zhang; Chao Zheng; Jie Zhu; Li Cui
Journal:  Mediators Inflamm       Date:  2018-04-17       Impact factor: 4.711

3.  Rps27a might act as a controller of microglia activation in triggering neurodegenerative diseases.

Authors:  Nasibeh Khayer; Mehdi Mirzaie; Sayed-Amir Marashi; Maryam Jalessi
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

4.  Interleukin 18 Polymorphisms and its serum level in Patients with Multiple Sclerosis.

Authors:  Hamidreza Jahanbani-Ardakani; Fereshteh Alsahebfosoul; Masoud Etemadifar; Seyed-Hossein Abtahi
Journal:  Ann Indian Acad Neurol       Date:  2019-10-25       Impact factor: 1.383

Review 5.  Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment.

Authors:  Stella Amarachi Ihim; Sharafudeen Dahiru Abubakar; Zeineb Zian; Takanori Sasaki; Mohammad Saffarioun; Shayan Maleknia; Gholamreza Azizi
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

Review 6.  Evidence of inflammatory system involvement in Parkinson's disease.

Authors:  Yinxia Chao; Siew Cheng Wong; Eng King Tan
Journal:  Biomed Res Int       Date:  2014-06-24       Impact factor: 3.411

Review 7.  The Absent in Melanoma 2-Like Receptor IFN-Inducible Protein 16 as an Inflammasome Regulator in Systemic Lupus Erythematosus: The Dark Side of Sensing Microbes.

Authors:  Valeria Caneparo; Santo Landolfo; Marisa Gariglio; Marco De Andrea
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.